Large-Joint Reconstructive Implants | Market Insights | Asia Pacific | 2022
COVID-19–related delays to hip and knee replacement procedures negatively impacted the US large-joint reconstructive implant market in 2020 and into 2021; however, the market saw strong year-over-year growth in 2021 overall, largely attributable to the rescheduling of procedures that were deferred in 2020. Following the short-term impact of the pandemic, the market will see long-term growth, driven by the uptake of novel technologies such as patient-conforming and 3-D printed implants, smart implants, robotic- and navigation-assisted surgeries, and minimally invasive techniques, although downward pricing pressures driven by bundled payment initiatives such as the CJR and BPCI Advanced models, growing outpatient joint replacement volumes, and the increasing influence of GPOs will limit overall revenue potential to some degree.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for large-joint reconstructive implants in the US across a 12-year period.
